Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Clinical trial NCT04092673 · UNKNOWN
Trial details
- NCT number
- NCT04092673
- Sponsor
- Effector Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-25
- Primary completion
- 2024-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.